Table 1.
Co-morbidities of participants in combined use of ADOS-2 Deaf adaptation and ADI-R Deaf adaptation validation study.
| Clinical Diagnoses * | Deaf Children with ASD (n = 58) n (%) |
Deaf Children without ASD (n = 58) n (%) |
|---|---|---|
| Genetic | ||
| Alport syndrome | 1 (1.7) | 1 (1.7) |
| Branchio-oto-renal syndrome | 0 (0) | 2 (3.4) |
| Chromosome 1q21.1 duplication syndrome | 1 (1.7) | 0 (0) |
| Chromosome 15 deletion | 0 (0) | 1 (1.7) |
| Connexin 26 | 3 (5.2) | 4 (6.9) |
| Mondini dysplasia | 1 (1.7) | 0 (0) |
| Pendred syndrome | 2 (3.4) | 2 (3.4) |
| X linked Stapes Gusher Syndrome | 0 (0) | 1 (1.7) |
| Waardenburg | 2 (3.4) | 4 (6.9) |
| XXY (Klinefelter syndrome) | 1 (1.7) | 0 (0) |
| Developmental | ||
| Dyspraxia/motor co-ordination disorder | 5 (8.6) | 4 (6.9) |
| Learning Disability | 14 (24.1) | 7 (12.1) |
| Language Delay | 18 (31) | 13 (22.4) |
| Von Hippel-Landau disease | 1 (1.7) | 0 (0) |
| Neurological/physical | ||
| Asthma | 6 (10.3) | 2 (3.4) |
| Aural atresia | 1 (1.7) | 0 (0) |
| Disorder of Vestibular Function | 0 (0) | 2 (3.4) |
| Cerebral palsy | 0 (0) | 2 (3.4) |
| Past Cytomegalovirus infection | 4 (6.9) | 1 (1.7) |
| Epilepsy | 1 (1.7) | 3 (5.2) |
| Hypermobility | 1 (1.7) | 0 (0) |
| Microcephaly | 0 (0) | 2 (3.4) |
| Multiple physical problems | 5 (8.6) | 1 (1.7) |
| Sensory processing disorder | 6 (10.3) | 4 (6.9) |
| Visual problems (more than acuity) | 1 (1.7) | 2 (3.4) |
| Mental health | ||
| Attention Deficit Hyperactivity Disorder | 5 (8.6) | 4 (6.9) |
| Conduct/Behaviour | 1 (1.7) | 3 (5.2) |
| Emotional (serious anxiety disorders) | 6 (10.3) | 6 (10.3) |
* Parent reported clinical diagnoses.